Effects of chronic fluoxetine treatment on anxious behaviour of BALB/c mice in a 3-dimensional maze

Abstract

Here we used a 3-dimensional (3D) maze, a modification of the radial maze, to assess the effects of treatment for two weeks with a single daily dose of fluoxetine (20 mg/kg, i.p.) on anxiety in male BALB/c mice. We examined whether anxiolytic effects of fluoxetine can be detected over three daily test sessions. We examined also whether repeated handling associated with chronic treatment interferes with effects of fluoxetine on anxiety responses. The 3D maze comprises nine arms, each connected to an upward inclined bridge radiating from a central platform. In this maze, BALB/c mice cross frequently into the bridges but avoid the arms. This avoidance is used as an index of anxiety. Two separate groups received once a day either saline (SALCH, n = 8) or fluoxetine (FLUCH, n = 8) for 14 days, and up to 30 min before the test during the subsequent 3 days. A third group received saline (SALAC, n = 8) 30 min before the test, once a day for 3 days. SALAC mice did not cross into the arms, and continued this avoidance over 3 sessions. SALCH mice avoided the arms in session 1 whereas FLUCH mice did cross into the arms, and like SALCH mice, increased number of crossings into and time on the arms in subsequent sessions. Fluoxetine evidently had an anxiolytic effect but only in the first session. These results indicate that handling experience decreased fear and anxiety in the mice, which may have masked the anxiolytic effect of fluoxetine in the second and third test sessions.

Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression

“…FLX effectively attenuates depressive-like behaviours in animal models when administered chronically3536. SSRIs are useful for treating acute depressive episodes and preventing subsequent episodes in MDD subjects43.…”

“…FLX hydrochloride (Sigma-Aldrich) was dissolved in drinking water at a concentration of 100 μg/mL to obtain a target mean drug dose of approximate 20 mg/kg/day, which is the highest chronic dose reported to be effective in mice3536. SSZ was dissolved in a small volume of 1 M NH 4 OH, which was then adjusted to pH 8.5 using 1 M HCl.…”

Preclinical animal anxiety research – flaws and prejudices

“…; Holmes and Rodgers ; Rodgers and Shepherd ).This lack of sensitivity makes it very difficult to predict the therapeutic potential of a drug, especially for chronic use, as it is possible that an initial reaction to a drug differs from its effects on subsequent uses (Abuhamdah et al. ; Cole and Pieper ; de Wit and Phillips ).…”

“…In a recent study (Abuhamdah et al. ), we used the 3D maze to assess the effects of fluoxetine (20 mg/kg, i.p.) on anxiety in BALB/c mice.…”

Examining the Roles of GABAA Receptor Subtypes in Anxiety and Anxiolysis: Focusing on the Basolateral Amygdala

“…Thus, both dopaminergic and serotonergic neurotransmission in the amygdala mainly promote fear and anxiety. This is in contrast with studies showing anxiolytic-like effects after chronic, systemic SSRI treatment that augmented extracellular serotonin level over a prolonged period of time (Abuhamdah, Hussain, Chazot, & Ennaceur, 2015;Dulawa, Holick, Gundersen, & Hen, 2004).…”